These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2083920)

  • 21. [Plasma catecholamine levels in liver disease].
    Krauns P; Ruge W
    Z Gastroenterol; 1985 Feb; 23(2):64-73. PubMed ID: 4060803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary porphyrins in liver disease.
    Ostrowski J; Kosecki P; Martyńska M; Milewski B
    Scand J Gastroenterol; 1984 Sep; 19(6):862-6. PubMed ID: 6515322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in total lactate dehydrogenase and its isoenzyme-5 in hepatic disorders.
    Rotenberg Z; Weinberger I; Davidson E; Fuchs J; Harell D; Agmon J
    Ann Clin Lab Sci; 1990; 20(4):268-73. PubMed ID: 2403242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
    Sathish Kumar N; Eapen CE; Jeyamani R; Balasubramanian KA
    Clin Chim Acta; 2004 Apr; 342(1-2):233-5. PubMed ID: 15026286
    [No Abstract]   [Full Text] [Related]  

  • 26. Human erythrocyte polyamine levels after partial hepatectomy.
    Tsukamoto T; Kinoshita H; Hirohashi K; Kubo S; Otani S
    Hepatogastroenterology; 1997; 44(15):744-50. PubMed ID: 9222683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.
    Ito K; Niwa M; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1986 Nov; 11(5):345-52. PubMed ID: 3672563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
    Zipser RD; Radvan GH; Kronborg IJ; Duke R; Little TE
    Gastroenterology; 1983 Apr; 84(4):697-703. PubMed ID: 6572162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the ketone body ratio in fulminant hepatic failure.
    Scaiola A; MacMathuna P; Langley PG; Gove CD; Hughes RD; Williams R
    Hepatogastroenterology; 1990 Aug; 37(4):413-6. PubMed ID: 2210609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of measuring urinary sulfated bile acids in adult patients with hepatobiliary diseases.
    Nanashima A; Obatake M; Sumida Y; Abo T; Yamane Y; Nomura M; Yuhio I; Sawai T; Takeshita H; Hidaka S; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2009; 56(90):299-302. PubMed ID: 19579586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation.
    Eguchi S; Yanaga K; Sugiyama N; Okudaira S; Furui J; Kanematsu T
    Liver Transpl; 2003 Jun; 9(6):547-51. PubMed ID: 12783393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
    Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
    Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional and morphological changes and liver regeneration after liver resection].
    Fëdorov VD; Vishnevskiĭ VA; Podkolzin AV
    Khirurgiia (Mosk); 1993 Jun; (6):14-21. PubMed ID: 8246381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
    McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
    Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased urinary polyamine excretion during liver regeneration.
    Anehus S; Yngner T; Hafström L; Heby O
    Biochem Med Metab Biol; 1986 Jun; 35(3):322-6. PubMed ID: 3718763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern and concentration of free and acetylated polyamines in urine of cirrhotic patients.
    Cecco L; Antoniello S; Auletta M; Cerra M; Bonelli P
    Int J Biol Markers; 1992; 7(1):52-8. PubMed ID: 1583348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.